Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Humira (Adalimumab) as Part of Routine Clinical Care.
Phase of Trial: Phase IV
Latest Information Update: 05 Dec 2012
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 13 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 17 May 2011 Status changed from recruiting to active, no longer recruiting.